Literature DB >> 14609940

Endophthalmitis after intravitreal injection of triamcinolone acetonide.

Jost B Jonas, Ingrid Kreissig, Robert F Degenring.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609940     DOI: 10.1001/archopht.121.11.1663-b

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  12 in total

1.  Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.

Authors:  B R Kosobucki; W R Freeman; L Cheng
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

2.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

3.  Effects of intravitreal triamcinolone acetonide injection with and without preservative.

Authors:  Mauricio Maia; Michel Eid Farah; Rubens N Belfort; Fernando Marcondes Penha; Acácio A S Lima Filho; Fabio Bom Aggio; Rubens Belfort
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

4.  Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study.

Authors:  Oswaldo Ferreira Moura Brasil; Scott D Smith; Anat Galor; Careen Y Lowder; Jonathan E Sears; Peter K Kaiser
Journal:  Br J Ophthalmol       Date:  2006-11-15       Impact factor: 4.638

5.  Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.

Authors:  U H M Spandau; M Derse; P Schmitz-Valckenberg; C Papoulis; J B Jonas
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

6.  Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.

Authors:  Tomoyo Koga; Yuki Mawatari; Junko Inumaru; Mikiko Fukushima; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-15       Impact factor: 3.117

7.  Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors.

Authors:  Ziad F Bashshur; Abdallah M Terro; Christelle P El Haibi; Akaber M Halawi; Alexandre Schakal; Baha' N Noureddin
Journal:  Clin Ophthalmol       Date:  2008-06

Review 8.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

9.  Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema.

Authors:  Joon Sung Bae; Sung Joon Park; I Rum Ham; Tae Gon Lee
Journal:  Korean J Ophthalmol       Date:  2009-06-09

10.  Sterile endophthalmitis rates and particle size analyses of different formulations of triamcinolone acetonide.

Authors:  David G Dodwell; Darrel A Krimmel; Christopher M de Fiebre
Journal:  Clin Ophthalmol       Date:  2015-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.